string(28) "" Next Page

Calculus joins Scottish biotech company fundraising with £3.5m investment

  Calculus Capital, the private equity fund manager, has invested a total of £3.5m in Scottish biotechnology company Synpromics. The investment was made via its Enterprise Investment Scheme Funds and Venture Capital Trust. Calculus was taking part in a £5.2m fundraising round together with Scottish Enterprise, the Scottish government’s economic development agency, and a group […]

To read the full story Subscribe Sign in